(2026)
William Paterson University (WPU) – Practice
Examination with NGN Case Scenarios
Questions 1–200
SECTION 1: PHARMACOKINETICS &
PHARMACODYNAMICS (Questions 1–40)
1. A patient with hepatic cirrhosis is prescribed a
medication with high first-pass metabolism. The NP
expects which pharmacokinetic change?
A. Decreased oral bioavailability
B. Increased oral bioavailability
C. Decreased volume of distribution
D. Increased renal clearance
Answer: B. Increased oral bioavailability
Rationale: In hepatic cirrhosis, liver function is impaired,
reducing first-pass metabolism. Drugs that normally
,undergo extensive hepatic metabolism will have less
degradation during their first pass through the liver,
resulting in increased systemic availability when taken
orally and a higher risk of toxicity .
2. A drug that is highly protein-bound is administered to
a patient with severe hypoalbuminemia. What is the
most likely pharmacokinetic consequence?
A. Decreased free drug concentration
B. Increased free drug concentration
C. Decreased elimination half-life
D. Reduced drug efficacy
Answer: B. Increased free drug concentration
Rationale: Low albumin levels reduce available binding
sites for drugs. This increases the fraction of unbound
(active) drug in plasma, which can enhance
pharmacologic effects and increase the risk of toxicity.
Even small changes in protein binding can double free
drug concentrations .
, 3. A medication follows zero-order kinetics. Which
k k k k k k
statement best describes its elimination?
k k k k k
A. A constant percentage of the drug is eliminated per unit
k k k k k k k k k k
time
k
B. Elimination depends on renal perfusion
k k k k k
C. A constant amount of the drug is eliminated per unit time
k k k k k k k k k k k
D. Elimination rate decreases as concentration increases
k k k k k k
Answer: C. A constant amount of the drug is eliminated per
k k k k k k k k k k
unit time
k k
Rationale: Zero-order elimination (e.g., phenytoin, high-
k k k k k
dose aspirin) saturates metabolic enzymes, eliminating a
k k k k k k
fixed amount per hour, leading to variable half-life. At very
k k k k k k k k k k
high concentrations, metabolic enzymes may saturate,
k k k k k k
shifting to zero-order kinetics .
k k k k k
4. A drug with a half-life of 12 hours is administered
k k k k k k k k k k
intravenously. Approximately how many hours until
k k k k k k
steady state is reached?
k k k k
A. 24 hours
k k
B. 36 hours
k k
C. 60 hours
k k
D. 120 hours
k k